000			01719 a2200469 4500
005			20250518005307.0
264		0	_c20200304
008			202003s 0 0 eng d
022			_a1549-4713
024	7		_a10.1016/j.ophtha.2018.10.040 _2doi
040			_aNLM _beng _cNLM
100	1		_aWeinreb, Robert N
245	0	0	_a24-Hour Intraocular Pressure Control with Fixed-dose Combination Brinzolamide 1%/Brimonidine 0.2%: A Multicenter, Randomized Trial. _h[electronic resource]
260			_bOphthalmology _c08 2019
300			_a1095-1104 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAntihypertensive Agents _xtherapeutic use
650	0	4	_aBrimonidine Tartrate _xtherapeutic use
650	0	4	_aCarbonic Anhydrase Inhibitors _xtherapeutic use
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGlaucoma, Open-Angle _xdrug therapy
650	0	4	_aHumans
650	0	4	_aIntraocular Pressure _xdrug effects
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOcular Hypertension _xdrug therapy
650	0	4	_aProspective Studies
650	0	4	_aSulfonamides _xtherapeutic use
650	0	4	_aThiazines _xtherapeutic use
700	1		_aBacharach, Jason
700	1		_aFechtner, Robert D
700	1		_aKahook, Malik Y
700	1		_aWirta, David
700	1		_aBurmaster, Steve
700	1		_aMeng, Xiangyi
700	1		_aHubatsch, Douglas A
773	0		_tOphthalmology _gvol. 126 _gno. 8 _gp. 1095-1104
856	4	0	_uhttps://doi.org/10.1016/j.ophtha.2018.10.040 _zAvailable from publisher's website
999			_c29019916 _d29019916